Denner L - Search Results

1

Induction of apoptosis in BPH stromal cells by adenoviral-mediated overexpression of caspase-7.

Marcelli M, Shao TC, Li X, Yin H, Marani M, Denner L, Teng B, Cunningham GR. Marcelli M, et al. Among authors: denner l. J Urol. 2000 Aug;164(2):518-25. J Urol. 2000. PMID: 10893637

2

Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.

Marcelli M, Cunningham GR, Haidacher SJ, Padayatty SJ, Sturgis L, Kagan C, Denner L. Marcelli M, et al. Among authors: denner l. Cancer Res. 1998 Jan 1;58(1):76-83. Cancer Res. 1998. PMID: 9426061

3

Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: overexpression of caspase-7 as a new gene therapy strategy for prostate cancer.

Marcelli M, Cunningham GR, Walkup M, He Z, Sturgis L, Kagan C, Mannucci R, Nicoletti I, Teng B, Denner L. Marcelli M, et al. Among authors: denner l. Cancer Res. 1999 Jan 15;59(2):382-90. Cancer Res. 1999. PMID: 9927051

4

Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation.

Marcelli M, Marani M, Li X, Sturgis L, Haidacher SJ, Trial JA, Mannucci R, Nicoletti I, Denner L. Marcelli M, et al. Among authors: denner l. Prostate. 2000 Mar 1;42(4):260-73. doi: 10.1002/(sici)1097-0045(20000301)42:4<260::aid-pros3>3.0.co;2-0. Prostate. 2000. PMID: 10679755

5

Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer.

Li X, Marani M, Yu J, Nan B, Roth JA, Kagawa S, Fang B, Denner L, Marcelli M. Li X, et al. Among authors: denner l. Cancer Res. 2001 Jan 1;61(1):186-91. Cancer Res. 2001. PMID: 11196158

6

Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells.

Li X, Marani M, Mannucci R, Kinsey B, Andriani F, Nicoletti I, Denner L, Marcelli M. Li X, et al. Among authors: denner l. Cancer Res. 2001 Feb 15;61(4):1699-706. Cancer Res. 2001. PMID: 11245486

7

Monogene and polygene therapy for the treatment of experimental prostate cancers by use of apoptotic genes bax and bad driven by the prostate-specific promoter ARR(2)PB.

Zhang Y, Yu J, Unni E, Shao TC, Nan B, Snabboon T, Kasper S, Andriani F, Denner L, Marcelli M. Zhang Y, et al. Among authors: denner l. Hum Gene Ther. 2002 Nov 20;13(17):2051-64. doi: 10.1089/10430340260395901. Hum Gene Ther. 2002. PMID: 12490000

8

Use of the probasin promoter ARR2PB to express Bax in androgen receptor-positive prostate cancer cells.

Andriani F, Nan B, Yu J, Li X, Weigel NL, McPhaul MJ, Kasper S, Kagawa S, Fang B, Matusik RJ, Denner L, Marcelli M. Andriani F, et al. Among authors: denner l. J Natl Cancer Inst. 2001 Sep 5;93(17):1314-24. doi: 10.1093/jnci/93.17.1314. J Natl Cancer Inst. 2001. PMID: 11535706

9

Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand.

Jiang JD, Denner L, Ling YH, Li JN, Davis A, Wang Y, Li Y, Roboz J, Wang LG, Perez-Soler R, Marcelli M, Bekesi G, Holland JF. Jiang JD, et al. Among authors: denner l. Cancer Res. 2002 Nov 1;62(21):6080-8. Cancer Res. 2002. PMID: 12414632

10

Nuclear factor-kappaB and cell death after experimental intracerebral hemorrhage in rats.

Hickenbottom SL, Grotta JC, Strong R, Denner LA, Aronowski J. Hickenbottom SL, et al. Among authors: denner la. Stroke. 1999 Nov;30(11):2472-7; discussion 2477-8. doi: 10.1161/01.str.30.11.2472. Stroke. 1999. PMID: 10548686

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters